BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20925909)

  • 1. An integrated analysis of molecular aberrations in NCI-60 cell lines.
    Yeang CH
    BMC Bioinformatics; 2010 Oct; 11():495. PubMed ID: 20925909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deciphering causal and statistical relations of molecular aberrations and gene expressions in NCI-60 cell lines.
    Li SD; Tagami T; Ho YF; Yeang CH
    BMC Syst Biol; 2011 Nov; 5():186. PubMed ID: 22051105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An integrative characterization of recurrent molecular aberrations in glioblastoma genomes.
    Sintupisut N; Liu PL; Yeang CH
    Nucleic Acids Res; 2013 Oct; 41(19):8803-21. PubMed ID: 23907387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis of urothelial cancer cell lines for modeling tumor biology and drug response.
    Nickerson ML; Witte N; Im KM; Turan S; Owens C; Misner K; Tsang SX; Cai Z; Wu S; Dean M; Costello JC; Theodorescu D
    Oncogene; 2017 Jan; 36(1):35-46. PubMed ID: 27270441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MethCNA: a database for integrating genomic and epigenomic data in human cancer.
    Deng G; Yang J; Zhang Q; Xiao ZX; Cai H
    BMC Genomics; 2018 Feb; 19(1):138. PubMed ID: 29433427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectrum of EGFR aberrations and potential clinical implications: insights from integrative pan-cancer analysis.
    Liu H; Zhang B; Sun Z
    Cancer Commun (Lond); 2020 Jan; 40(1):43-59. PubMed ID: 32067422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying master regulators of cancer and their downstream targets by integrating genomic and epigenomic features.
    Gevaert O; Plevritis S
    Pac Symp Biocomput; 2013; ():123-34. PubMed ID: 23424118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA expression profiles for the NCI-60 cancer cell panel.
    Blower PE; Verducci JS; Lin S; Zhou J; Chung JH; Dai Z; Liu CG; Reinhold W; Lorenzi PL; Kaldjian EP; Croce CM; Weinstein JN; Sadee W
    Mol Cancer Ther; 2007 May; 6(5):1483-91. PubMed ID: 17483436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies.
    Berg KCG; Eide PW; Eilertsen IA; Johannessen B; Bruun J; Danielsen SA; Bjørnslett M; Meza-Zepeda LA; Eknæs M; Lind GE; Myklebost O; Skotheim RI; Sveen A; Lothe RA
    Mol Cancer; 2017 Jul; 16(1):116. PubMed ID: 28683746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated analysis of DNA copy number and gene expression microarray data using gene sets.
    Menezes RX; Boetzer M; Sieswerda M; van Ommen GJ; Boer JM
    BMC Bioinformatics; 2009 Jun; 10():203. PubMed ID: 19563656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated analysis of miRNAs and DNA methylation identifies miR-132-3p as a tumor suppressor in lung adenocarcinoma.
    Su Y; Shetty A; Jiang F
    Thorac Cancer; 2020 Aug; 11(8):2112-2124. PubMed ID: 32500672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer driver gene discovery through an integrative genomics approach in a non-parametric Bayesian framework.
    Yang H; Wei Q; Zhong X; Yang H; Li B
    Bioinformatics; 2017 Feb; 33(4):483-490. PubMed ID: 27797769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic and epigenetic aberrations of chromosome 1p36.13 have prognostic implications in malignancies.
    Naderi A
    Chromosome Res; 2020 Dec; 28(3-4):307-330. PubMed ID: 32816122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient representations of tumor diversity with paired DNA-RNA aberrations.
    Ke Q; Dinalankara W; Younes L; Geman D; Marchionni L
    PLoS Comput Biol; 2021 Jun; 17(6):e1008944. PubMed ID: 34115745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systems analysis identifies miR-29b regulation of invasiveness in melanoma.
    Andrews MC; Cursons J; Hurley DG; Anaka M; Cebon JS; Behren A; Crampin EJ
    Mol Cancer; 2016 Nov; 15(1):72. PubMed ID: 27852308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elucidation of molecular links between obesity and cancer through microRNA regulation.
    Dogan H; Shu J; Hakguder Z; Xu Z; Cui J
    BMC Med Genomics; 2020 Oct; 13(1):161. PubMed ID: 33121472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling the DNA copy number aberration patterns in observational high-throughput cancer data.
    van Wieringen WN; Roś BP; Wilting SM
    Stat Appl Genet Mol Biol; 2013 Apr; 12(2):143-74. PubMed ID: 23735435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells.
    Drexler HG
    Leukemia; 1998 Jun; 12(6):845-59. PubMed ID: 9639410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the NCI-60 dataset for cancer-related microRNA and mRNA using expression profiles.
    Weng CW; Lee SC; Lee YL; Ng KL
    Comput Biol Chem; 2013 Jun; 44():15-21. PubMed ID: 23499870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single cell genomics reveals activation signatures of endogenous SCAR's networks in aneuploid human embryos and clinically intractable malignant tumors.
    Glinsky GV
    Cancer Lett; 2016 Oct; 381(1):176-93. PubMed ID: 27497790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.